Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions.
about
Protein C inhibitor and serum amyloid A in immune thrombocytopaenic purpura.Levels of thrombopoietin in aqueous humor of patients with noninfectious acute anterior uveitis.Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatmentThe impact of eltrombopag administration on the clinical course of severe refractory fatal acquired aplastic anemia.Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis.Lack of platelet activation reflected by circulating soluble glycoprotein V in pre-eclampsia.
P2860
Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Thrombopoietin as a drug: biol ...... lities, and future directions.
@ast
Thrombopoietin as a drug: biol ...... lities, and future directions.
@en
type
label
Thrombopoietin as a drug: biol ...... lities, and future directions.
@ast
Thrombopoietin as a drug: biol ...... lities, and future directions.
@en
prefLabel
Thrombopoietin as a drug: biol ...... lities, and future directions.
@ast
Thrombopoietin as a drug: biol ...... lities, and future directions.
@en
P2093
P2860
P1476
Thrombopoietin as a drug: biol ...... lities, and future directions.
@en
P2093
Hakan Goker
Mehmet Turgut
Mustafa Benekli
Yahya Buyukasik
P2860
P304
P356
10.1177/107602960200800301
P577
2002-07-01T00:00:00Z